The global Phase III VANCE trial of the autologous EBV-targeted T-cell therapy was the largest trial of a solid tumor cell ...

Experience convenient blood cancer treatment close to home. Find out how this unique partnership brings autologous stem cell ...

Lehigh Valley Topper Cancer Institute, which is now part of the NCI Designated Sidney Kimmel Comprehensive Cancer Center at Jefferson Health, has announced it is now offering treatment using ...

The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...

When it comes to cell therapy, Alloplex Biotherapeutics Inc. CEO Frank Borriello said he believes that autologous, personalized therapy is the only thing that makes sense. “The allure of an ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data ...

The UK’s proposed regulations would provide the legal framework for POC manufacturing, including quality assurance.

Santhosh K. Sadashiv, MD, discusses the role of chimeric antigen receptor T-cell therapy in patients with multiple myeloma.

FDA assigns PDUFA target action date of April 29, 2025CLEVELAND, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABEO) today ...